XLV
Health Care Select Sector SPDR Fund, Health, State Street Investment Management.
Data through 2026-09-02
View as Markdown
Cost per year
0.08%
$8 a year on $10,000
Positions
61
60.7% in the ten largest
Assets
$41.7B
under management
Return, 3 years
35.1%
cumulative, total return
Volatility
14.7%
annualised, 3 years of weekly returns
Worst fall
-17.1%
peak to trough, 3 years
What XLV duplicates
Owning XLV alongside any of these means holding the same companies twice. The first column is the share of combined weight sitting in companies both funds hold.
| Fund | Overlap by weight | Share of XLV also held there | Share of that fund also in XLV | Companies in both | |
|---|---|---|---|---|---|
| VHT | 85.3% | 100.0% | 85.4% | 59 | |
| DGRO | 18.5% | 75.9% | 18.5% | 26 | |
| SCHD | 17.9% | 20.9% | 21.6% | 5 | |
| VIG | 17.7% | 69.3% | 17.7% | 22 | |
| VTV | 15.6% | 73.9% | 15.6% | 36 | |
| SPYV | 13.1% | 80.8% | 13.1% | 54 | |
| DIA | 13.0% | 26.2% | 14.1% | 4 | |
| VYM | 13.0% | 55.1% | 13.0% | 20 | |
| RSP | 12.8% | 100.0% | 13.2% | 59 | |
| IBB | 12.5% | 12.6% | 39.4% | 9 | |
| USMV | 12.5% | 69.4% | 13.0% | 20 | |
| VOOV | 12.5% | 80.8% | 12.5% | 53 |
Measured across the 61 US ETFs covered here, from the issuer files published on the dates below. Check any other pair.
What it holds
| Rank | Company | Weight | |
|---|---|---|---|
| 1 | LLY | 14.82% | |
| 2 | JNJ | 10.54% | |
| 3 | ABBV | 7.42% | |
| 4 | MRK | 5.98% | |
| 5 | UNH | 5.81% | |
| 6 | AMGN | 3.82% | |
| 7 | TMO | 3.6% | |
| 8 | ABT | 3.06% | |
| 9 | GILD | 3.01% | |
| 10 | PFE | 2.63% | |
| 11 | VRTX | 2.25% | |
| 12 | BMY | 2.21% | |
| 13 | ISRG | 2.11% | |
| 14 | DHR | 2.11% | |
| 15 | CVS | 2.01% | |
| 16 | MDT | 1.91% | |
| 17 | SYK | 1.77% | |
| 18 | MCK | 1.76% | |
| 19 | ELV | 1.41% | |
| 20 | REGN | 1.33% | |
| 21 | CI | 1.21% | |
| 22 | BSX | 1.15% | |
| 23 | COR | 1.04% | |
| 24 | HCA | 1.04% | |
| 25 | CAH | 0.91% |
The 25 largest of 61 positions, from the issuer file published 01-Sep-2026.
Cost, returns and risk
| Expense ratio | 0.08% |
|---|---|
| Dividend yield | 1.56% |
| Total return, 1 year | 27.0% |
| Total return, 3 years cumulative | 35.1% |
| Total return, 5 years cumulative | 36.2% |
| Volatility, annualised | 14.7% |
| Worst fall, 3 years | -17.1% |
| Beta against the S&P 500 | 0.42 |
| Weight in the ten largest positions | 60.7% |
| Largest single position | 14.8% |
| Assets under management | $41.7B |
How it moves with the market
| Against | Correlation, 3 years | Covariance, annualised (%2) |
|---|---|---|
| SPY | 0.41loosely linked | 87 |
| QQQ | 0.24barely linked | 68 |
Weekly total returns. Divide a covariance by the two volatilities to get the correlation beside it. What the bands mean
Year by year
| Year | Total return |
|---|---|
| 2026 | 11.8% |
| 2025 | 14.5% |
| 2024 | 2.5% |
| 2023 | 2.1% |
| 2022 | -2.1% |
One year
XLV 126
SPY 117
2025-09-122026-09-04
Where to go next
- IBB, iShares Biotechnology ETF
- VHT, Vanguard Health Care ETF
- Run a portfolio x-ray to see what XLV carries once you look through it
Holdings from the issuer file published 01-Sep-2026. Prices through 2026-09-02. How every figure here is produced. Measurements, not investment advice.
